Carnegie Investment Counsel’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.6M Sell
251,518
-88,126
-26% -$8.04M 0.43% 68
2026
Q1
$33.5M Buy
339,644
+20,846
+7% +$2.35M 0.65% 44
2025
Q4
$39.9M Buy
318,798
+9,703
+3% +$1.24M 0.74% 29
2025
Q3
$41.4M Buy
309,095
+1,205
+0.4% +$158K 0.78% 28
2025
Q2
$41.9M Buy
307,890
+6,328
+2% +$834K 0.84% 25
2025
Q1
$38.5M Buy
301,562
+104,013
+53% +$13.2M 0.91% 21
2024
Q4
$22.3M Buy
197,549
+3,551
+2% +$410K 0.64% 41
2024
Q3
$22.1M Sell
193,998
-2,659
-1% -$292K 0.65% 41
2024
Q2
$20.4M Sell
196,657
-5,904
-3% -$626K 0.64% 42
2024
Q1
$23M Buy
202,561
+4,830
+2% +$554K 0.72% 39
2023
Q4
$21.8M Sell
197,731
-5,009
-2% -$500K 0.75% 39
2023
Q3
$19.6M Sell
202,740
-5,445
-3% -$572K 0.75% 37
2023
Q2
$22.7M Sell
208,185
-1,892
-0.9% -$202K 0.84% 28
2023
Q1
$21.3M Sell
210,077
-321
-0.2% -$33.9K 0.85% 30
2022
Q4
$23.1M Buy
210,398
+1,472
+0.7% +$152K 0.99% 21
2022
Q3
$20.2M Sell
208,926
-7,623
-4% -$812K 0.96% 21
2022
Q2
$23.5M Sell
216,549
-19,496
-8% -$2.21M 1.06% 18
2022
Q1
$27.9M Buy
236,045
+4,162
+2% +$516K 1.02% 20
2021
Q4
$32.6M Buy
231,883
+38,858
+20% +$4.97M 1.08% 20
2021
Q3
$22.8M Buy
193,025
+1,314
+0.7% +$161K 0.86% 29
2021
Q2
$22.2M Buy
191,711
+7,450
+4% +$868K 0.84% 28
2021
Q1
$22.1M Buy
184,261
+10,998
+6% +$1.3M 0.93% 25
2020
Q4
$19M Buy
173,263
+55,599
+47% +$6.04M 0.85% 27
2020
Q3
$12.8M Buy
117,664
+4,623
+4% +$469K 0.65% 49
2020
Q2
$10.3M Buy
113,041
+2,516
+2% +$227K 0.59% 54
2020
Q1
$8.72M Buy
110,525
+15,425
+16% +$1.29M 0.61% 52
2019
Q4
$8.26M Buy
95,100
+5,489
+6% +$460K 0.48% 67
2019
Q3
$7.5M Buy
89,611
+702
+0.8% +$59.6K 0.48% 65
2019
Q2
$7.48M Buy
88,909
+2,299
+3% +$181K 0.49% 57
2019
Q1
$6.92M Buy
86,610
+1,885
+2% +$140K 0.48% 60
2018
Q4
$6.13M Sell
84,725
-11,585
-12% -$814K 0.57% 49
2018
Q3
$6.94M Buy
96,310
+30,693
+47% +$2.02M 0.57% 50
2018
Q2
$4.16M Buy
65,617
+3,508
+6% +$213K 0.32% 95
2018
Q1
$3.8M Buy
62,109
+3,212
+5% +$194K 0.32% 92
2017
Q4
$3.45M Buy
58,897
+13,521
+30% +$749K 0.31% 99
2017
Q3
$2.54M Sell
45,376
-658
-1% -$33K 0.3% 98
2017
Q2
$2.27M Buy
46,034
+1,178
+3% +$53.3K 0.28% 108
2017
Q1
$2M Sell
44,856
-2,132
-5% -$92.2K 0.25% 112
2016
Q4
$1.86M Sell
46,988
-219
-0.5% -$8.68K 0.25% 115
2016
Q3
$1.92M Sell
47,207
-939
-2% -$40.2K 0.28% 103
2016
Q2
$2.1M Buy
48,146
+1,777
+4% +$70.7K 0.3% 98
2016
Q1
$1.94M Buy
46,369
+1,787
+4% +$70.8K 0.3% 98
2015
Q4
$1.69M Sell
44,582
-377
-0.8% -$16.6K 0.29% 95
2015
Q3
$1.97M Buy
44,959
+1,407
+3% +$66.3K 0.34% 82
2015
Q2
$2.14M Buy
43,552
+1,877
+5% +$90.1K 0.37% 85
2015
Q1
$1.95M Buy
41,675
+3,241
+8% +$149K 0.34% 89
2014
Q4
$1.75M Buy
38,434
+3,702
+11% +$161K 0.33% 90
2014
Q3
$1.44M Buy
+34,732
New +$1.47M 0.29% 99

Other funds holding ABT

Carnegie Investment Counsel's ABT Position: Q2 2026 in Review

Carnegie Investment Counsel reduced its Abbott (ABT) stake by 26% in Q2 2026, selling an estimated $8.04M and leaving 251,518 shares worth $21.6M. The position accounts for 0.43% of the portfolio, ranked #68.

Carnegie Investment Counsel first reported a position in ABT in Q3 2014 and has held it in 48 quarters since. The position peaked at $41.9M in Q2 2025. 1,390 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Carnegie Investment Counsel held 251,518 shares of Abbott worth $21.6M as of Q2 2026.
  • Carnegie Investment Counsel sold 88,126 Abbott shares in Q2 2026, an estimated $8.04M.
  • Abbott made up 0.43% of Carnegie Investment Counsel's portfolio in Q2 2026, its #68 holding.
  • Carnegie Investment Counsel first reported a position in Abbott in Q3 2014 and has held it in 48 quarters since.
  • Carnegie Investment Counsel's Abbott position peaked at $41.9M in Q2 2025.
  • 1,390 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Carnegie Investment Counsel's 13F filing for Q2 2026, filed 30 Jul 2026.